Skip to content
Screener

Monte Rosa Therapeutics, Inc. GLUE Klybeckstrasse Lease — Increase Decrease In Operating Lease Liability

Similar metrics at other companies

EyePoint, Inc. logo
EYPTWatertown Massachusetts — Increase Decrease In Operating Lease Liability
$600K
Clearfield logo
CLFDBrooklyn Park MN — Increase Decrease In Operating Lease Liability
$3.55M
Avalo Therapeutics logo
AVTXMaryland — Increase (Decrease) in Operating Lease Liability
-$300K0.0%
Opendoor Technologies Inc logo
OPENTempe, Arizona Office — Increase (Decrease) in Operating Lease Liability
-$7M
SharkNinja logo
SNIncrease Decrease In Operating Lease Liability
-$5.28M-19.9%
SLD
SLDPIncrease Decrease In Operating Lease Liability
-$230K+39.2%

Other financials

Income statement

See full
Revenue$9.0M-61.3%
Operating income-$49.1M-216%
Net income-$43.4M-253%
EPS (diluted)-$0.43-187%

Balance sheet

See full
Cash & equivalents$90.1M+29.8%
Total debt$38.0M-7.6%
Total equity$487.3M+81.8%
Total assets$691.2M+92.2%

Cash flow

See full
Operating cash flow-$44.1M-27.1%
CapEx$4.7M+179%
Free cash flow-$48.8M-34.1%

Valuation

See full
Market cap$1.35B+422%
Enterprise value$1.3B+463%
P/S47×+45.5×

Profitability

See full
Operating margin-633%
Net margin-560.8%
FCF margin-111.7%-125pp

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.1×-0.1×
Current ratio10.6×+3.4×

Where this comes from

Reported directly by Monte Rosa Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:09 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336711

In March 2021, the Company entered into an operating lease agreement, or the Klybeckstrasse Lease, for office and laboratory space with Wincasa AG, or the Basel Landlord, that occupies approximately 21,422 square feet located at Klybeckstrasse 191, 4057 Basel, Basel-City, Switzerland. In April 2023, the Company and the Basel Landlord amended the Klybeckstrasse Lease which increased the office and laboratory space square footage from 21,422 square feet to 44,685 square feet and extended the term of the lease through June 30, 2027. In March 2026, the Company and the Basel Landlord again amended the Klybeckstrasse Lease, the Second Amendment, to extend the term of the lease through June 30, 2028. The Second Amendment was accounted for as a lease modification and resulted in increases to the related ROU asset and operating lease liability of $1.0 million.

Item 1. Financial Statements

FAQ

What is Monte Rosa Therapeutics, Inc.'s klybeckstrasse lease — increase decrease in operating lease liability?
Monte Rosa Therapeutics, Inc. (GLUE) reported klybeckstrasse lease — increase decrease in operating lease liability of $1M in Q1 2026.
What does klybeckstrasse lease — increase decrease in operating lease liability mean?
This metric represents the net change in the recognized lease liability associated with the Klybeckstrasse facility, reflecting adjustments for new lease agreements, modifications, or remeasurements. It captures the financial impact of the company's commitment to this specific real estate asset over the lease term. Monitoring this value helps investors understand the company's fixed-cost obligations and capital expenditure strategy related to its physical infrastructure.

Ask your AI about Monte Rosa Therapeutics, Inc.'s klybeckstrasse lease — increase decrease in operating lease liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude